FHTX · NASDAQ · Biotechnology

Foghorn Therapeutics

Develops oncology drugs from a Gene Traffic Control discovery platform.

$6.00
After-hours close0.00 (0.00%)
At close$6.00(−3.54%)
DateEstimateReportedSurprise
Nov 2026−$0.23
Aug 2026−$0.25−$0.10+59.2%
May 2026−$0.28−$0.29−3.6%
Mar 2026−$0.28−$0.34−21.4%
Nov 2025−$0.31−$0.25+19.4%

The latest year is open to everyone — the 28 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Dec 2020
Oct 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Mar 2019
Jun 2018
Mar 2018
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 4, 2026−$0.23$7.1M
Aug 6, 2026−$0.25−$0.10+59.2%$6.8M$16.1M+136.6%
May 7, 2026−$0.28−$0.29−3.6%$7.9M$3.3M−58.9%
Mar 11, 2026−$0.28−$0.34−21.4%$10.2M$9.2M−8.9%
Nov 5, 2025−$0.31−$0.25+19.4%$9.5M$8.2M−14.2%

The latest year is open to everyone — the 28 quarters behind it read with an account.

Sign in
Aug 5, 2025
May 14, 2025
Mar 6, 2025
Nov 4, 2024
Aug 8, 2024
May 6, 2024
Mar 7, 2024
Nov 2, 2023
Aug 4, 2023
May 8, 2023
Mar 9, 2023
Nov 8, 2022
Aug 9, 2022
May 9, 2022
Mar 10, 2022
Nov 9, 2021
Aug 10, 2021
May 11, 2021
Mar 18, 2021
Dec 4, 2020
Oct 23, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019
Jun 30, 2018
Mar 31, 2018